Walgreens partly paring decline on report of Sycamore deal talks
Walgreens Boots (NASDAQ:WBA) pared a bit of its decline amid a report that private equity firm Sycamore Partners is talking ...
As Walgreens Looks to Save Cash, Suitor Sycamore Seeks Funding
Walgreens Boots Alliance Inc.’s chairman and biggest shareholder, Stefano Pessina, has dealmaking in his DNA. Yet finding a ...
kffhealthnews3d
Walgreens Unlikely To Sell To Private Equity Firm Sycamore Partners
Pharmacy chain Walgreens has been struggling for over a year and has been in talks to sell to Sycamore Partners, a deal that is now "mostly dead." Meanwhile, some independent pharmacies are opting to ...
Drug Store News4d
Walgreens buyout talks reportedly unlikely to culminate in a deal
A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York ...
Becker's Hospital Review3d
Walgreens private equity sale 'mostly dead': Report
Sources told CNBC's David Faber that a private equity firm's prospective deal to acquire Walgreens Boots Alliance is ...
Crain's Chicago Business4d
Walgreens stock tumbles on report that private equity deal is unlikely
Shares of Walgreens Boots Alliance tumbled today following a CNBC report that the Deerfield-based pharmacy chain was unlikely ...
Walgreens Boots slides after CNBC’s Faber calls Sycamore deal ‘mostly dead’
Shares of Walgreens Boots Alliance (WBA) are down about 3% to $11.49 in early trading after CNBC’s David Faber said on-air that his sources ...
Walgreens Stock Falls on Concerns Potential Buyout Deal is ‘Dead’
Shares of Walgreens Boots Alliance tumbled after a report that the pharmacy chain’s talks to sell itself to a private-equity firm are unlikely to result in a deal. CNBC’s David Faber said on air his s ...